Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aytu Biopharma (AYTU) Preferred Shares (2017 - 2020)

Aytu Biopharma (AYTU) has disclosed Preferred Shares for 4 consecutive years, with $981.0 as the latest value for Q1 2020.

  • On a quarterly basis, Preferred Shares rose 319.23% to $981.0 in Q1 2020 year-over-year; TTM through Mar 2020 was $981.0, a 319.23% increase, with the full-year FY2019 number at $359.0, changed N/A from a year prior.
  • Preferred Shares was $981.0 for Q1 2020 at Aytu Biopharma, down from $1022.0 in the prior quarter.
  • In the past five years, Preferred Shares ranged from a high of $1022.0 in Q4 2019 to a low of $1.0 in Q3 2017.
  • A 4-year average of $420.75 and a median of $337.0 in 2019 define the central range for Preferred Shares.
  • Peak YoY movement for Preferred Shares: soared 45200.0% in 2018, then skyrocketed 125.61% in 2019.
  • Aytu Biopharma's Preferred Shares stood at $1.0 in 2017, then skyrocketed by 45200.0% to $453.0 in 2018, then surged by 125.61% to $1022.0 in 2019, then decreased by 4.01% to $981.0 in 2020.
  • Per Business Quant, the three most recent readings for AYTU's Preferred Shares are $981.0 (Q1 2020), $1022.0 (Q4 2019), and $315.0 (Q3 2019).